TWO SIGMA ADVISERS, LP - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 107 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2019. The put-call ratio across all filers is 3.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q3 2022$3,000
-57.1%
16,800
+20.0%
0.00%
Q1 2022$7,0000.0%14,000
+23.9%
0.00%
Q4 2021$7,000
-90.4%
11,300
-71.8%
0.00%
Q2 2021$73,000
-86.2%
40,000
-85.1%
0.00%
-100.0%
Q1 2021$529,000
+812.1%
268,600
+482.6%
0.00%
Q4 2020$58,000
-86.7%
46,100
-11.5%
0.00%
-100.0%
Q2 2020$437,000
+498.6%
52,100
+288.8%
0.00%
Q4 2019$73,000
-29.1%
13,400
-36.8%
0.00%
Q3 2019$103,00021,2000.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,738,925$23,555,00031.22%
Perceptive Advisors 1,232,500$7,764,0000.39%
IFP Advisors, Inc 1,001,025$6,306,0000.27%
WOODSTOCK CORP 55,489$350,0000.07%
Virtus ETF Advisers LLC 50,795$320,0000.05%
Dynamic Technology Lab Private Ltd 31,431$198,0000.04%
Evanson Asset Management, LLC 20,660$130,0000.03%
Artal Group S.A. 250,000$1,575,0000.03%
GSA CAPITAL PARTNERS LLP 58,800$370,0000.02%
Raymond James Financial Services Advisors, Inc. 426,280$2,686,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders